News & Events
- June 14, 2017 - June 15, 2017
June 12, 2017
Critical Path for Parkinson’s Consortium 2017 Annual MeetingThe Critical Path for Parkinson’s (CPP) Consortium, cofounded by C-Path and Parkinson’s UK, held its second annual consortium member meeting on June 12 in Bethesda, MD. The meeting brought together scientists from the biopharmaceutical industry, academic institutions, and government agencies; people living with Parkinson’s; patient-advocacy associations; and U.S. Food and Drug Administration regulators to align on the...
June 6, 2017
Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO ConsortiumThis webinar provides a recommended framework for the selection and evaluation of wearable devices and their measurements for use in regulatory trials to support labeling claims. The webinar will also address the essential properties of fit-for-purpose wearables and the activities required to establish clinical endpoints derived from data collected with wearable devices. Presenters: Bill Byrom,...
June 6, 2017 - June 7, 2017
Drug-Induced Liver Injury (DILI) Conference XVIIAsymmetry of Drug Safety and Efficacy in Clinical Trials with DILI- Toward Quantitative Estimate of Net Benefit to Patients June 6, 2017 – June 7, 2017 College Park Marriott Hotel and Conference Center Paul Watkins, Mark Avigan, John-Michael Sauer, Arie Regev, Gyongyi Szabo, John Senior Drug-induced liver injury (DILI) is a major problem for drug...
June 4, 2017 - June 8, 2017
Critical Path for Parkinson’s Consortium Posters from the 21st International Congress of Parkinson’s Disease and Movement DisordersC-Path’s Critical Path for Parkinson’s Consortium (CPP) presented three posters at the 21st International Congress of Parkinson’s Disease and Movement Disorders, held June 4-8 in Vancouver, BC, Canada. The posters highlight the consortium’s work in regulatory science and drug development tools for Parkinson’s. The first poster details global regulatory support in using dopamine transporter neuroimaging...